New Mexico Pharmacy Practice Act and Board of Pharmacy Regulatory Framework
Where the rules live
New Mexico pharmacy law has three layers: the Pharmacy Practice Act (NMSA 1978, Chapter 61, Article 11), the Board of Pharmacy rules codified in Title 16, Chapter 19 NMAC, and Board guidance such as policy statements, inspection forms and newsletters. When layers conflict, the statute controls the rule and the rule controls guidance. Questions love to quote a policy statement as though it were law.
Board powers
A governor-appointed Board with pharmacist and public members licenses pharmacists, pharmacist clinicians, interns, technicians and pharmacy sites; adopts rules; sets fees; inspects pharmacies; and disciplines licensees. It also administers New Mexico's Controlled Substances Act and the state prescription monitoring program. Adjudicatory hearings follow the New Mexico Uniform Licensing Act (NMSA 61-1-1 et seq.), which supplies notice, hearing and appeal procedure.
Distinctive New Mexico features
Scope of practice is broader than in most states: pharmacist clinician prescriptive authority, protocol-based immunizing and self-care prescribing, naloxone/opioid antagonist distribution, and collaborative practice arrangements. Expect questions asking whether a plain pharmacist, a pharmacist clinician, or a Board-approved protocol is required for a given act.
Rule of thumb
Analyze in three steps: (1) Does the Act permit the activity at all? (2) Does a Board rule set conditions? (3) Does this pharmacist hold the credential or protocol the rule requires? A 'no' at any step ends the analysis. Board rules cannot enlarge statutory authority, so an activity authorized only by rule and beyond the Act is vulnerable.